Chronic Hepatitis b: Clinical Trials

5 trials for Chronic Hepatitis b, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 recruiting. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Recruiting 5

Follow Chronic Hepatitis b: new trials by email Literature Review of Chronic Hepatitis b trials Research Report on Chronic Hepatitis b

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chronic Hepatitis B Virus Infection
Anti-PD-L1 antibody (ASC22), Nucleotide analogs, Peg-IFNα - Chronic Hepatitis b
Phase 4RecruitingThe Second Affiliated Hospital of Chongqing Medical University1202024-05-212026-09-01
SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus
Dapagliflozin 10mg Tab, Placebo 10mg Tab - Chronic Hepatitis B
Phase 4RecruitingChinese University of Hong Kong4122024-03-262026-03-18
Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease(OCEAN PROJECT)
Peg-Interferon α - Nonalcoholic Fatty Liver Disease, Chronic Hepatitis b
Phase 4RecruitingFirst Affiliated Hospital of Wenzhou Medical University15002024-01-012024-04-16
Study of Tenofovir Alafenamide in HBV-Infected Pregnant Women
Tenofovir Alafenamide Tablets - Chronic Hepatitis b, Tenofovir Alafenamide Fumarate
Phase 4RecruitingFirst People's Hospital of Hangzhou502021-05-062025-09-08
Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK)
Stop current treatment (anti-HBV neucleos(t)ides), Keep current treatment (anti-HBV neucleos(t)ides) - Chronic Hepatitis B
Phase 4RecruitingHumanity & Health Medical Group Limited20002018-12-012025-03-24

Narrower conditions

Hepatitis B, Chronic (5)  ·  Non-alcoholic Fatty Liver Disease (1)

Broader conditions

Blood-Borne Infections (5)  ·  Chronic Disease (5)  ·  Communicable Diseases (5)  ·  DNA Virus Infections (5)  ·  Digestive System Diseases (5)  ·  Disease Attributes (5)  ·  Hepadnaviridae Infections (5)  ·  Hepatitis (5)  ·  Hepatitis B (5)  ·  Hepatitis, Chronic (5)  ·  Hepatitis, Viral, Human (5)  ·  Infections (5)  ·  Liver Diseases (5)  ·  Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)

Interventions

Tenofovir (1)  ·  dapagliflozin (1)  ·  entecavir (1)  ·  tenofovir alafenamide (1)

Sponsors

Chinese University of Hong Kong (1)  ·  First Affiliated Hospital of Wenzhou Medical University (1)  ·  First People's Hospital of Hangzhou (1)  ·  Humanity & Health Medical Group Limited (1)  ·  The Second Affiliated Hospital of Chongqing Medical University (1)

Countries

China (3)  ·  Hong Kong (2)

Top investigators

Grace LH Wong, MD (1)  ·  Hong Ren, MM (1)  ·  Siying Li, MD (1)  ·  Zhiyuan Ma, PhD (1)